Alteplase
Links shared publicly online about this topic
Alteplase For Stroke Treatment-Sooner The Better, Later The Risks
medicalnewstoday.com — “After a stroke, the thrombolytic ('clot-busting') drug alteplase needs to be given as soon as possible, as benefits on clinical recovery and prevention of early deaths fall rapidly as the time to” View full resource at medicalnewstoday.com
Most Recently Shared on May 17, 2010 at 5:45 pm By:
Alteplase For Stroke Treatment-Sooner The Better, Later The Risks: After a stroke, the thrombolytic ('clot-busting... http://mnt.to/f/3CJ2
Experts call for licence extension of stroke drug alteplase | Healthcare Republic
healthcarerepublic.com — “Experts call for licence extension of stroke drug alteplase | Healthcare Republic” View full resource at healthcarerepublic.com
Most Recently Shared on July 27, 2010 at 12:44 pm By:
Experts call for licence extension of stroke drug alteplase: Stroke drug alteplase should have its licence extende... http://bit.ly/a8SzXw
Tenecteplase vs. Alteplase for Ischemic Stroke | Now@NEJM
blogs.nejm.org — “Though, for clinicians, ordering a drug these days is as simple as a click of a button, for the drug, getting to within reach of our fingertips is no easy feat.” View full resource at blogs.nejm.org
Most Recently Shared on March 21, 2012 at 9:16 pm By:
@NEJM Tenecteplase vs. Alteplase for Ischemic Stroke http://t.co/89wzJGNW #medical #journal
Symposier - Activase t PA MOA Mechanism of Action Activase® Alteplase
symposier.com — “Uploaded and Shared in Youtube by: cestafan Activase t PA MOA Mechanism of Action Activase® Alteplase” View full resource at symposier.com
Most Recently Shared on February 13, 2010 at 2:50 am By:
Activase t-PA MOA Mechanism of Action. Approved for treating heart attacks and acute massive pulmonary embolism. http://bit.ly/a6Kc64
Tenecteplase vs. Alteplase for Ischemic Stroke | Now@NEJM
blogs.nejm.org — “Though, for clinicians, ordering a drug these days is as simple as a click of a button, for the drug, getting to within reach of our fingertips is no easy feat.” View full resource at blogs.nejm.org
Most Recently Shared on March 24, 2012 at 1:01 pm By:
Tenecteplase’s future for acute ischemic #stroke, writes Rosenbaum on Now@NEJM blog, remains a big ‘what if.’ http://t.co/jf63stP7
Tenecteplase vs. Alteplase for Ischemic Stroke | Now@NEJM
blogs.nejm.org — “Though, for clinicians, ordering a drug these days is as simple as a click of a button, for the drug, getting to within reach of our fingertips is no easy feat.” View full resource at blogs.nejm.org
Most Recently Shared on March 25, 2012 at 4:13 pm By:
Big step forward for tenecteplase on its road to becoming a new option for treatment of acute ischemic stroke - NEJM http://t.co/fHveM3Bc
Arquivos Brasileiros de Cardiologia - Analysis of the cost-effectiveness of thrombolysis with alteplase in stroke
scielo.br — “Arquivos Brasileiros de Cardiologia - Analysis of the cost-effectiveness of thrombolysis with alteplase in stroke” View full resource at scielo.br
Most Recently Shared on August 19, 2010 at 11:04 am By:
Analysis of the cost-effectiveness of thrombolysis with alteplase in stroke: CONCLUSION: The thrombolytic therapy ... http://bit.ly/cyj2Bx
Emergency Medicine News - A Randomized Trial of Tenecteplase versus Alteplase for Acute Ischemic Stroke |3991612
mdlinx.com — “Emergency Medicine Medical Article: A Randomized Trial of Tenecteplase versus Alteplase for Acute Ischemic Stroke” View full resource at mdlinx.com
Most Recently Shared on March 23, 2012 at 10:44 am By:
A Randomized Trial of Tenecteplase versus Alteplase for Acute Ischemic Stroke: New England Journal of Medicine http://t.co/pfc9q9ax #ER
Magnetic Resonance Angiography Identifies Stroke Patients Unlikely to Respond to Alteplase - QualityPoint Technologies
qualitypointtech.net — “Stroke patients with proximal occlusions identified by magnetic resonance angiography (MRA) are unlikely to respond to treatment with alteplase, researchers from Japan report in the October 28th online issue of Stroke. Reuters Health Information” View full resource at qualitypointtech.net
Most Recently Shared on November 26, 2010 at 6:02 pm By:
Magnetic Resonance Angiography Identifies Stroke Patients Unlikely to Respond to Alteplase: Stroke patients with p... http://bit.ly/g6nku9
Implementation and outcome of thrombolysis with alteplase 3"4'5 h after an acute stroke: an updated analysis from SITS-ISTR : The Lancet Neurology
thelancet.com — “Implementation and outcome of thrombolysis with alteplase 3"4'5 h after an acute stroke: an updated analysis from SITS-ISTR. By - Niaz Ahmed MD, Prof Nils Wahlgren MD, Prof Martin Grond MD, Prof Mi...” View full resource at thelancet.com
Most Recently Shared on July 27, 2010 at 8:44 am By:
Study confirms benefit and safety of extending treatment window for stroke to 4.5 hours http://bit.ly/dc9QDX
SYNTHESIS Expansion: design of a nonprofit, pragmatic, randomized, controlled trial on the best fast-track endovascular treatment vs. standard intravenous alteplase for acute ischemic stroke - Ciccone - 2011 - International Journal of Stroke - Wiley Onlin
onlinelibrary.wiley.com — “SYNTHESIS Expansion: design of a nonprofit, pragmatic, randomized, controlled trial on the best fast-track endovascular treatment vs. standard intravenous alteplase for acute ischemic stroke - Ciccone - 2011 - International Journal of Stroke - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on March 19, 2011 at 5:17 am By:
SYNTHESIS Expansion: design of a nonprofit, pragmatic, randomized, controlled trial on the best fastâ€*track end... http://bit.ly/if2jtx
SYNTHESIS Expansion: design of a nonprofit, pragmatic, randomized, controlled trial on the best fast-track endovascular treatment vs. standard intravenous alteplase for acute ischemic stroke - Ciccone - 2011 - International Journal of Stroke - Wiley Onlin
onlinelibrary.wiley.com — “SYNTHESIS Expansion: design of a nonprofit, pragmatic, randomized, controlled trial on the best fast-track endovascular treatment vs. standard intravenous alteplase for acute ischemic stroke - Ciccone - 2011 - International Journal of Stroke - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on March 18, 2011 at 11:24 pm By:
SYNTHESIS Expansion: design of a nonprofit, pragmatic, randomized, controlled trial on the best fastâ€*track end... http://bit.ly/if2jtx
Confirmation To Back Extension Of Treatment Window For Stroke To 4.5 Hours (ECASS III Study)
medicalnewstoday.com — “Research published from ecass iii has suggested that alteplase leads to better outcomes than placebo in stroke patients in the 3.0 to 4.5 hour window after a stroke. an article published online fi” View full resource at medicalnewstoday.com
Most Recently Shared on October 21, 2009 at 10:34 am By:
Confirmation To Back Extension Of Treatment Window For Stroke To 4.5 Hours (ECASS III Study): Research publishe.. http://bit.ly/FoZfr
Early Treatment With Clot-Busting Drug Best After Stroke - Drugs.com MedNews
drugs.com — “Patients who get the clot-busting drug alteplase (tPA) within 4.5 hours of having a stroke fare better than patients who are given the drug later, Scottish doct” View full resource at drugs.com
Most Recently Shared on May 14, 2010 at 10:59 pm By:
Early Treatment With Clot-Busting Drug Best After Stroke - http://bit.ly/dqWXKK
News in brief : The Lancet Neurology
thelancet.com — “News in brief.” View full resource at thelancet.com
Most Recently Shared on December 14, 2010 at 9:44 am By:
[In Context] News in brief: is widely recommended for treatment of acute ischaemic stroke in patients under 80 y... http://bit.ly/hhNfTl
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
Neurology OW
Organizing neurology resources shared by health experts, advocates, and organizations into WisdomCards.
-
Stroke OW
Organizing stroke and mini-stroke resources shared by health experts, advocates, and organizations into WisdomCards.
-
Thomas Loarie, Jr
Medical Health Information you can use! I'm committed to finding positive, useful, educational and hopefully inspirational medical health news!
Advertisement

